ConductScience.org, home

Paper2331748

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Zack JA and 5 others. Cell, 1990. Cited by 1,415 papers, by iCite.

Cite this record

ConductScience Library. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Papers, record 2331748. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2331748

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
PubMed
Journal
Cell
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,415
iCite
Relative citation ratio, by iCite
29.8
iCite
Revised in PubMed
2024-01-04
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zack JAJ A
2Arrigo SJS J
3Weitsman SRS R
4Go ASA S
5Haislip AA
6Chen ISI S

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIVMajor topic
Lymphocyte ActivationMajor topic
T-LymphocytesMajor topic
Base Sequence
DNA, Viral
Gene Expression
Genes, Viral
HIV-1
Humans
Molecular Sequence Data
Oligonucleotide Probes
Polymerase Chain Reaction
RNA, Viral

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AI27221NIAID NIH HHSUnited StatesU01AI027221PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by698

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,415 citations.

PMIDTitleJournalYearIn PapersSource
42947143Virus-informed targeting of HIV reservoirs: Rev-dependent HIV Immunotherapy (RHIT).Retrovirology2026https://conductscience.org/library/papers/42947143PubMed
42092137HIV-1 signalling remodels nuclear pores to licence infection.Nature2026https://conductscience.org/library/papers/42092137PubMed
41942453In vivo CAR T cell generation using retargeted and functionalized lentiviral vectors with reduced immunogenicity.Nat Commun2026https://conductscience.org/library/papers/41942453PubMed
41600872Tools to Quantify and Characterize the Persistent Reservoir in People with HIV-1: Focus on Non-B Subtypes.Viruses2026https://conductscience.org/library/papers/41600872PubMed
41000984Partially-functional exhausted CD8+ T cells can contribute to short-term viral suppression: a computational prediction for children with perinatal HIV.bioRxiv2025https://conductscience.org/library/papers/41000984PubMed
40934271Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy.PLoS Pathog2025https://conductscience.org/library/papers/40934271PubMed
40464563Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure.J Virol2025https://conductscience.org/library/papers/40464563PubMed
40332080Prime Editing in Dividing and Quiescent Cells.Int J Mol Sci2025https://conductscience.org/library/papers/40332080PubMed
40148322Keratin-72 restricts HIV-1 infection in resting CD4+ T cells by sequestering capsids in intermediate filaments.Nat Commun2025https://conductscience.org/library/papers/40148322PubMed
40048262Divergent populations of HIV-infected naive and memory CD4+ T cell clones in children on antiretroviral therapy.J Clin Invest2025https://conductscience.org/library/papers/40048262PubMed
40044684Tracking HIV persistence across T cell lineages during early ART-treated HIV-1-infection using a reservoir-marking humanized mouse model.Nat Commun2025https://conductscience.org/library/papers/40044684PubMed
39066325HIV Persistence, Latency, and Cure Approaches: Where Are We Now?Viruses2024https://conductscience.org/library/papers/39066325PubMed
38765786Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells.Pathog Immun2024https://conductscience.org/library/papers/38765786PubMed
38675857Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies.Viruses2024https://conductscience.org/library/papers/38675857PubMed
38010468The Role of p53 in HIV Infection.Curr HIV/AIDS Rep2023https://conductscience.org/library/papers/38010468PubMed
37844236Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37844236PubMed
37345240HIV Preintegration Transcription and Host Antagonism.Curr HIV Res2023https://conductscience.org/library/papers/37345240PubMed
37159665DNA ultra-sensitive quantification, a technology for studying HIV unintegrated linear DNA.Cell Rep Methods2023https://conductscience.org/library/papers/37159665PubMed
37111397HIV Infection Elicits Differential Transcriptomic Remodeling in CD4+ T Cells with Variable Proliferative Responses to the T Cell Receptor Stimulus.Pathogens2023https://conductscience.org/library/papers/37111397PubMed
37110276HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an "Emerging Syndemic".Microorganisms2023https://conductscience.org/library/papers/37110276PubMed

See all 698 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2331748

GET https://conductscience.org/api/papers/v1/2331748/cited_by?page=2